An added advantage of the purpose built, CITE-enabled system is that it can help transform the 80 percent of the non-active spaces in healthcare facilities, including hallways, waiting rooms and staging areas, into active care zones.

As the only FDA-grade, safe, and secure medical journey platform, Phrazer/Kitsune has proven a new model of care that is equitable, efficient and effective

One of the most significant instances of Phrazer/ Kitsune’s relevance is enunciated in its adoption by COVID-19 response centers in a major metropolitan area. Facilities are responsible for mass screenings and care of diverse populations with varied ages, cultures and language backgrounds. Almost 50 percent of patients are non-English speakers, and many are functionally illiterate. Given the situation with conventional methods, the staff members and translators have to speak to each patient on a one-to-one basis that involves gowning up in PPE, screening the patient, disposing the PPE, and then repeating the process all over again. This is extremely time-consuming, ineffective and a challenge for both caregivers and patients. By contrast, GeaCom’s Phrazer/Kitsune engages patients directly, dynamically adjusts to their demographic, and keeps them connected with staff in a safe way that ensures a proper and effective patient flow. The platform’s patents include real time cues to staff members about the patient’s status, symptoms, concerns and best practices to engage with them. Needless to say, it enables them to establish seamless and safe communication between the patient and staff. When appropriate, the platform initiates a full discharge after patients are marked ‘safe to go home’. In contrast, some patients are sent to the COVID inpatient unit, where they maintain continuous communication with the staff members through GeaCom’s platform. These patients easily interact with physicians and nurses via Phrazer/Kitsune’s secure video conferencing or messaging system, enabling one staff member to effectively and safely provide ongoing and quality care to more than ten patients, simultaneously.

“GeaCom has matured to a point where we can do extremely well in today’s market scenario - during the pandemic and beyond. As the only FDA-grade, safe, and secure medical journey platform, Phrazer/Kitsune has proven a new model of synchronous and asynchronous engagements that is scalable and effective while providing economic benefits. For over a decade, the GeaCom team and its partners have refined, proven, and employed this novel solution to great effect in dozens of use cases with 100s of demographies across all areas of care. The results are groundbreaking with the value found nowhere else,” concludes Katja Kressmann, General Manager at GeaCom.